{"id":"W3082062836","doi":"10.1016/j.annonc.2020.08.2100","title":"Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":276,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto","funders":"AstraZeneca","keywords":"Medicine; Osimertinib; Pemetrexed; T790M; Tyrosine-kinase inhibitor; Oncology; Internal medicine; non-small cell lung cancer (NSCLC); Tyrosine kinase; Cancer research; Chemotherapy; Epidermal growth factor receptor; Erlotinib; Cisplatin; Gefitinib; Lung cancer; Cancer; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002585995,0.0006778893,0.001549494,0.0004012761,0.0002598832,0.0007727035,0.0005201096,0.000868285,0.003007312],"category_scores_gemma":[0.001455488,0.0002889961,0.003711689,0.0004080556,0.0004028766,0.000734485,0.0004462488,0.001877203,0.0002531858],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008998764,"about_ca_system_score_gemma":0.0008401157,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001211461,"about_ca_topic_score_gemma":0.003226605,"domain_scores_codex":[0.9991621,0.0003638416,0.0000696428,0.0001422272,0.00007615531,0.0001860547],"domain_scores_gemma":[0.9987267,0.0003818173,0.0002964815,0.00007288202,0.00004779218,0.0004744841],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9266173,0.00291461,0.03455093,0.0003654135,0.004171013,0.00009621245,0.00008703151,0.001812208,0.002695353,0.0001519674,0.001472782,0.02506517],"study_design_scores_gemma":[0.300151,0.4083459,0.2631682,0.0001544574,0.01123637,0.0004528176,0.0002251181,0.008526491,0.002503809,0.00109119,0.004040831,0.0001038472],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952741,0.002157143,0.0001970924,0.0001921641,0.00009755414,0.0002371499,0.0009125929,0.00001420094,0.0009181326],"genre_scores_gemma":[0.9974307,0.0005491249,0.0001571605,0.0001797062,0.0001153679,0.0002177758,0.0007638443,0.000004422474,0.0005819597],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003007312,"threshold_uncertainty_score":0.01367623,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04921131033398256,"score_gpt":0.4076607989523607,"score_spread":0.3584494886183782,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}